WALTHAM, MA –– Repligen Corporation (NASDAQ:RGEN) today reported financial results for its fourth quarter and year ended December 31, 2012. The Company reported total revenue for the three-month period ended December 31, 2012 of $18,814,000, an increase of $11,649,000 as compared to total revenue of $7,165,000 for the same period in 2011. Revenue growth for […]
Goettingen, – At today’s meeting, the Supervisory Board of Sartorius AG approved the recommendation by the Executive Board to submit a proposal to the Annual Shareholders’ Meeting on April 18, 2013, to pay dividends of 0.96 euro per preference share (previous year: 0.82 euro) and 0.94 euro per ordinary share (previous year: 0.80 euro). If […]
MINNEAPOLIS — MOCON, Inc. (NASDAQ: MOCO) announced today that on February 28, 2013, its Board of Directors declared a quarterly cash dividend of eleven cents ($0.11) per share, payable on May 17, 2013, to shareholders of record on May 3, 2013. This is a five percent increase over the previous rate of ten and one-half […]
SAN DIEGO, — TriLink BioTechnologies, Inc. (TriLink, trilinkbiotech.com) was recently awarded a Phase I SBIR Grant of approximately $130,000 by the National Institutes of Health to develop an approach to RNA sample preparation for Next Generation Sequencing (NGS) using TriLink’s expertise in nucleic acid chemistry. This is the sixth Phase I grant TriLink has been […]
Berlin, Germany, – BioGenes GmbH, a global leader in host cell protein (HCP) assay development, announced a strong increase in sales volume in 2012, the year of the company’s 20th anniversary, due to a high demand of specific antibodies and ELISA assays used in drug development processes. In particular, the HCP assay development business showed […]
Aubagne | Goettingen, – At yesterday’s meeting, the Board of Directors of Sartorius Stedim Biotech S.A. resolved to submit a proposal to the Annual General Shareholders’ Meeting (AGM) on April 16, 2013, to pay a dividend of €1.10 per share for fiscal 2012. Compared with a year earlier, dividends per share would increase by 10.0% […]
Agilent Technologies Inc. (NYSE: A) today announced that Dr. Ronald A. DePinho, a world-renowned oncologist and researcher, has received an Agilent Thought Leader Award. DePinho is president of the University of Texas MD Anderson Cancer Center. The award will support his research into metabolic reprogramming in the earliest stages of cancer. DePinho and his team […]
WALTHAM, Mass.–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has declared a quarterly cash dividend of $0.15 per share. The dividend will be paid on April 15, 2013, to shareholders of record as of March 15, 2013. About Thermo Fisher Scientific Thermo Fisher Scientific […]
BEDFORD, Mass., — Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that it has commenced a registered exchange offer (the Exchange Offer) to exchange up to $1 billion aggregate […]
WASHINGTON, D.C., — Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.025 per share payable on April 26, 2013 to holders of record on March 28, 2013.
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
